Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.

Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schiffman M, Hildesheim A, Wilcox AJ, Wacholder S; Costa Rica HPV Vaccine Trial (CVT) Group (see end of manuscript for full list of investigators).

BMJ. 2015 Sep 7;351:h4358. doi: 10.1136/bmj.h4358.

2.

Long-term efficacy and safety of human papillomavirus vaccination.

De Vincenzo R, Conte C, Ricci C, Scambia G, Capelli G.

Int J Womens Health. 2014 Dec 3;6:999-1010. doi: 10.2147/IJWH.S50365. eCollection 2014. Review.

3.

Preconception care: preventing and treating infections.

Lassi ZS, Imam AM, Dean SV, Bhutta ZA.

Reprod Health. 2014 Sep 26;11 Suppl 3:S4. doi: 10.1186/1742-4755-11-S3-S4. Epub 2014 Sep 26. Review.

4.

Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.

Hildesheim A, Wacholder S, Catteau G, Struyf F, Dubin G, Herrero R; CVT Group.

Vaccine. 2014 Sep 3;32(39):5087-97. doi: 10.1016/j.vaccine.2014.06.038. Epub 2014 Jul 10.

5.

Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme.

Angelo MG, David MP, Zima J, Baril L, Dubin G, Arellano F, Struyf F.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):466-79. doi: 10.1002/pds.3554. Epub 2014 Feb 20.

6.

Is administration of the HPV vaccine during pregnancy feasible in the future?

Berenson AB, Patel PR, Barrett AD.

Expert Rev Vaccines. 2014 Feb;13(2):213-9. doi: 10.1586/14760584.2014.867236. Epub 2013 Nov 28. Review.

7.

Survey of human papillomavirus types and their vertical transmission in pregnant women.

Hong Y, Li SQ, Hu YL, Wang ZQ.

BMC Infect Dis. 2013 Feb 27;13:109. doi: 10.1186/1471-2334-13-109.

8.

A review of clinical trials of human papillomavirus prophylactic vaccines.

Schiller JT, Castellsagué X, Garland SM.

Vaccine. 2012 Nov 20;30 Suppl 5:F123-38. doi: 10.1016/j.vaccine.2012.04.108. Review.

9.

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.

Herrero R, Wacholder S, Rodríguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A; Costa Rica Vaccine Trial Group.

Cancer Discov. 2011 Oct;1(5):408-19. doi: 10.1158/2159-8290.CD-11-0131. Epub 2011 Sep 9.

10.

Human papillomavirus vaccine and pregnancy.

Narducci A, Einarson A, Bozzo P.

Can Fam Physician. 2012 Mar;58(3):268-9.

11.

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females.

Harper DM, Vierthaler SL.

ISRN Obstet Gynecol. 2011;2011:457204. doi: 10.5402/2011/457204. Epub 2011 Nov 2.

12.

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.

Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S; CVT Vaccine Group.

J Natl Cancer Inst. 2011 Oct 5;103(19):1444-51. doi: 10.1093/jnci/djr319. Epub 2011 Sep 9.

13.

Major clinical research advances in gynecologic cancer in 2010.

Suh DH, Kim JW, Kim K, Kang SB.

J Gynecol Oncol. 2010 Dec 30;21(4):209-18. doi: 10.3802/jgo.2010.21.4.209. Epub 2010 Dec 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk